TIMOLOL 0.25% GEL-SOLUTION

What it is

TIMOLOL 0.25% GEL-SOLUTION is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “timolol maleate”, “timolol maleate ophthalmic gel forming solution”, “timolol maleate ophthalmic gel forming solution 0.25%” and “timolol maleate ophthalmic gel forming solution, 0.25%”, as its NDCs’ listings variously write the nonproprietary name, under the trade name “Timolol GFS”.

FDA gives its dosage form as “solution, gel forming / drops”, “solution/ drops” and “solution” and its route as ophthalmic.

FDA lists 7 labelers (the companies named on the label) for its NDCs, among them Sagent Pharmaceuticals, Dr. Reddy's Laboratories, Inc. and Sandoz Inc.

FDA’s Established Pharmacologic Class for it is beta-Adrenergic Blocker.

The NADAC file of 2026-10-14 prices it under 8 NDCs (National Drug Codes); the FDA directory lists 7 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $31.88 for 5 mL (5 × $6.37609 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

What NADAC measures · NADAC explanation codes

The 7 labelers

Other strengths, forms and brands

8 other products in the NADAC file share an FDA nonproprietary name with TIMOLOL 0.25% GEL-SOLUTION.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-17, 2026-07-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 8 NDCs’ NADAC prices is $6.37609 per ML filed.

Of the 19 other products in FDA’s beta-Adrenergic Blocker class priced per ML, 10 have a higher middle NADAC price and 9 a lower one. The one in the middle is TIMOLOL 0.5% GEL-SOLUTION, at $8.30197 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $10.05 for 5 mL, at an average of $2.00991 per ML in 2024 (2024-01-01 to 2024-12-31) for “Timolol Maleate*” and “Timolol Maleate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 2,958,063 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

5 of the product’s 8 NDCs have this Medicare figure; the other 3 do not, and the interactive card says why for each.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 5 mL? Is it lower than what I would pay through my insurance?
• How much is in the package I am getting? This page uses 5 mL; your package may hold a different amount.
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.